Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Clinical trial NCT02853929 · COMPLETED

Trial details

NCT number: NCT02853929
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diphtheria Hepatitis B Acellular Pertussis Haemophilus Influenzae Type b Tetanus Poliomyelitis Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Start date: 2016-09-19
Primary completion: 2019-03-19
Enrollment: 551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.